
New US guidelines recommend earlier lipid-lowering therapy for patients with borderline or intermediate cardiovascular risk to prevent long-term disease.
Clinicians are advised to use the PREVENT risk calculator for patients aged 30 to 79 to estimate 10-year and 30-year cardiovascular disease risk.
Target LDL-C levels are set at below 100 mg/dL for intermediate risk and below 55 mg/dL for patients at very high risk of cardiovascular events.